Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin-fentanyl versus midazolam-fentanyl for pain and anxiety during cataract surgery
IRCT20160307026950N41Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jul 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, triple-blind trial in cataract comparing Melatonin + fentanyl with Midazolam + fentanyl (2 arms). Primary endpoints: Amount of sedation and Amount of pain. Started Jul 2022; status: completed.
02
Drugs
melatoninmidazolamfentanyl
03
Conditions
cataract
Beyond the preview
Go deeper on IRCT20160307026950N41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160307026950N41.